Cargando…
Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies
The drug pipeline for the treatment of inflammatory bowel disease (IBD) has dramatically expanded over the last two decades, and it is expected to further grow in the upcoming years with the introduction of new agents with different mechanisms of action. However, such an increase of therapeutic opti...
Autores principales: | Pugliese, Daniela, Onali, Sara, Privitera, Giuseppe, Armuzzi, Alessandro, Papi, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697479/ https://www.ncbi.nlm.nih.gov/pubmed/36431194 http://dx.doi.org/10.3390/jcm11226717 |
Ejemplares similares
-
The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”
por: Pugliese, Daniela, et al.
Publicado: (2020) -
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study
por: Dragoni, Gabriele, et al.
Publicado: (2023) -
Sailing charted seas: biomechanics and the orthopedic surgeon
por: Arangio, George A
Publicado: (2008) -
Rough medicine: surgeons at sea in the age of sail
por: Macdonald, Fiona A
Publicado: (2003) -
Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
por: Privitera, Giuseppe, et al.
Publicado: (2021)